Veltassa (partiromer) added to hospital formulary

Veltassa (partiromer) has been added to the health system's formulary, replacing Kayexalate (SPS) for adult patients.

Here are some key things to know:

• Partiromer has a more favorable side effect and safety profile than sodium polystyrene sulfonate (SPS)
• Patiromer comes in 8.4g powder packets for oral suspension and is dosed daily for chronic use
• This medication does not replace emergent hyperkalemia regimens and should be used adjunctively just like SPS; the recommended dose in this setting is 8.4g
• Partiromer should not be given rectally
• Pediatric patients should continue to use SPS
  

Questions? Call the Pharmacy.